High-Titer Lentivirus Solutions in 5 Days: Break Production Barriers for CGT

Lentiviral vectors are indispensable tools in cell and gene therapy (CGT) research, due to their ability to stably integrate genetic material into both dividing and non-dividing cells. Their versatility makes them particularly well-suited for delivering a wide range of payloads — from classical gene addition constructs to complex multi-cistronic CARs, CRISPR-Cas components and regulatory circuits that enable precise expression control.

As CGT advances toward more sophisticated platforms, including in vivo delivery, lentiviral vectors are playing an increasingly critical role. In this webinar, we will focus on the latest innovations driving the application of lentiviral systems in CGT therapy, particularly in vivo CAR-T therapies. Industry experts will share advanced strategies in vector design, packaging optimization and producer cell line engineering that significantly improve viral yields, enhance gene delivery in hard-to-transduce cells and ensure consistent, high-quality functional titers.

Speaker-related Webinars